Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Xenon Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
XENE
Nasdaq
2836
www.xenon-pharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Xenon Pharmaceuticals Inc.
Xenon to Present at Stifel 2025 Virtual CNS Forum
- Mar 12th, 2025 8:01 pm
Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus
- Feb 28th, 2025 2:36 pm
Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...
- Feb 28th, 2025 7:36 am
Xenon Pharmaceuticals: Q4 Earnings Snapshot
- Feb 27th, 2025 9:18 pm
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
- Feb 27th, 2025 9:01 pm
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
- Feb 25th, 2025 9:01 pm
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
- Feb 20th, 2025 9:01 pm
We're Not Very Worried About Xenon Pharmaceuticals' (NASDAQ:XENE) Cash Burn Rate
- Feb 2nd, 2025 12:43 pm
Xenon Outlines Key Corporate Milestone Opportunities for 2025
- Jan 13th, 2025 1:30 pm
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Jan 7th, 2025 1:30 pm
Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
- Dec 12th, 2024 4:30 pm
Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024
- Dec 6th, 2024 9:01 pm
Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
- Nov 25th, 2024 1:30 pm
JPMorgan Selects These 2 Stocks as Must-Haves for 2025
- Nov 22nd, 2024 2:30 pm
Xenon to Present at Upcoming Investor Conferences
- Nov 13th, 2024 9:01 pm
Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus
- Nov 13th, 2024 3:50 pm
Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
- Nov 13th, 2024 7:17 am
Xenon Pharmaceuticals: Q3 Earnings Snapshot
- Nov 12th, 2024 9:07 pm
Xenon Reports Q3 2024 Financial Results and Business Update
- Nov 12th, 2024 9:01 pm
Xenon to Report Q3 2024 Financial Results on November 12, 2024
- Nov 5th, 2024 9:01 pm
Scroll